Adrian Filipovic

Associate
  • Gothenburg
  • Languages:
    Swedish, English

Education

  • Stockholm University - Master of Laws (LL.M.) 2020,
  • Stockholm University Degree of Bachelor of Science in Business Administration 2020
  • University of Zürich 2019

Experience

  • Associate, Baker McKenzie 2020-2021
  • Summer associate, Baker McKenzie 2019
  • Legal intern, Nordea Asset Management, 2019

Mandates

Mandate June 07, 2022

Vinge advises Paynova in conjunction with raising of capital and change in listing

Vinge has advised Paynova AB, under change of name to Sileon AB, in connection with a fully subscrib…

Mandate April 29, 2022

Vinge has advised Promimic AB (publ) in connection with its listing on Nasdaq First North Growth Market

Vinge has advised Promimic AB (publ) in connection with its listing on Nasdaq First North Growth Mar…

Mandate November 09, 2021

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue whereby the c…

Mandate November 01, 2021

Vinge advises Smart Eye in connection with a capital procurement of MSEK 220

Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish…

Mandate October 15, 2021

Vinge has advised Byggfakta in connection with its listing on Nasdaq Stockholm

The first day of trading on Nasdaq Stockholm large cap was 15 October 2021. The offer price was SEK…

Mandate October 08, 2021

Vinge advises BICO in connection with a directed issue of new shares for SEK 2 billion

Vinge has advised BICO Group AB in connection with a directed issue of new shares for approximately…

Mandate September 03, 2021

Vinge advises Irisity in conjunction with the acquisition of Agent Vi and a directed share issue

Vinge has advised Irisity AB (publ) in connection with its acquisition of all shares in the Israeli…

Mandate July 29, 2021

Vinge advises Surgical Science in conjunction with a directed new issue of shares valued at SEK 2.7 billion

Surgical Science Sweden AB, listed on Nasdaq First North Growth Market, has performed a directed new…